Product Development

Ceres' world-class science team is focused on researching and developing the Nanotrap®'s capabilities to meet market needs for advanced biomarker discovery, screening and diagnostic tools.

Ceres is conducting cutting-edge science in its own labs while taking advantage of the ground breaking discoveries coming out of George Mason University's advanced labs. Several Ceres research projects are already well underway, including the development of better methods for scaled up Nanotrap® synthesis, the study of baseline HGH capture through the Nanotrap® in human urine and serum, and the development of multiple reagents for enhanced biomarker discovery. Ceres greatly benefits from other Nanotrap® studies being performed by the university through its lucrative licensing arrangement with rights to commercialize any new Nanotrap®-related discoveries.

Ceres has established a cutting-edge research lab where advanced Nanotrap® research and production are being performed. Our research team focuses both on the development of new Nanotrap® products and the refinement of Nanotrap® production processes for commercial scale.

Flexible and Customizable Technology

The Ceres Nanotrap® technology provides a highly flexible platform that can be customized to meet a variety of diagnostic needs while maintaining its core strengths of concentration and preservation capabilities. Ceres works collaboratively with its end-user customers and channel partners to fully understand their specific needs for diagnostic technologies. In turn, Ceres will either tailor an existing platform particle to meet specific needs, or will develop a new variety of Nanotrap® particle as necessary. Our team of scientists can quickly analyze, assess, and match your diagnostic needs to our technology's capabilities.

For more information on current products, planned products, or development opportunities, please contact us at info@ceresnano.com